Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists

E-ISSN： 1875-6417|5|4|266-275

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.5, Iss.4, 2009-11, pp. : 266-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome

Current Vascular Pharmacology, Vol. 15, Iss. 3, 2017-04 ,pp. : 218-229

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

By Holst J.J.

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 6, 1999-08 ,pp. : 229-235

Elsevier

Access to resources Recommend Favorite

Effect of Glucagon-like Peptide-2 (GLP-2) on Diurnal SGLT1 Expression

By Ramsanahie Anthony Berger Urs Zinner Michael Whang Edward Rhoads David Ashley Stanley

Digestive Diseases and Sciences, Vol. 49, Iss. 11-12, 2004-11 ,pp. : 1731-1737

Springer Publishing Company

Access to resources Recommend Favorite

GLP-1 receptor agonists in the treatment of Type 2 diabetes

By Ahrén Bo

Diabetes Management, Vol. 3, Iss. 5, 2013-09 ,pp. : 401-413

Future Medicine

Access to resources Recommend Favorite

Glucagon Like Peptide-1 (GLP-1) Dynamics Following Bariatric Surgery: A Signpost to a New Frontier

Current Diabetes Reviews, Vol. 9, Iss. 2, 2013-03 ,pp. : 93-101

Bentham Science Publishers

Access to resources Recommend Favorite